Related Experiment Video
Updated: Jan 15, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Drug targeting of protein-nucleic acid interactions
Luca R Genz1, Sanjana Nair2, Aaron Sweeney2
1Research Department of Integrative Virology, Leibniz-Institut für Virologie (LIV), Hamburg, Germany; Department of Chemistry, Universität Hamburg, Hamburg, Germany; Centre for Structural Systems Biology (CSSB), Hamburg, Germany.
Targeting protein-nucleic acid interactions, previously "undruggable," is now possible. New strategies enable therapeutic intervention in gene regulation for treating diseases like cancer and genetic disorders.
Area of Science:
- Molecular Biology
- Drug Discovery
- Genetics
Background:
- Protein-nucleic acid interactions are crucial for gene regulation and disease pathogenesis.
- These interactions have historically been considered difficult to target therapeutically.
- Recent breakthroughs are enabling the development of drugs targeting these interactions.
Purpose of the Study:
- To review current strategies for therapeutically targeting protein-nucleic acid interactions.
- To highlight key examples and emerging techniques in this field.
- To discuss the potential of these approaches in treating various diseases.
Main Methods:
- Review of scientific literature on protein-nucleic acid interaction targeting.
- Categorization of four major therapeutic strategies: direct disruption, stabilization, targeted degradation, and allosteric modulation.
- Analysis of examples involving transcription factors, RNA-binding proteins, and DNA repair proteins.
Main Results:
- Four primary strategies for targeting protein-nucleic acid interactions have been identified.
- Emerging chemical, structural, and computational methods are accelerating drug discovery.
- These approaches are expanding the range of druggable targets within the genome.
Conclusions:
- Therapeutic targeting of protein-nucleic acid interactions is a rapidly advancing field.
- These strategies offer new avenues for treating cancer, genetic disorders, and viral infections.
- Intervention in gene regulatory machinery holds significant therapeutic promise.
More Related Videos
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Protein-protein Interfaces
Drug-Receptor Bonds
In...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...